Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1M Sell
38,455
-3,627
-9% -$930K 0.11% 67
2026
Q2
$10.6M Buy
42,082
+1,463
+4% +$315K 0.11% 60
2026
Q1
$8.83M Sell
40,619
-4,863
-11% -$1.08M 0.1% 62
2025
Q4
$10.4M Sell
45,482
-1,017
-2% -$232K 0.12% 60
2025
Q3
$10.8M Buy
46,499
+486
+1% +$99K 0.12% 58
2025
Q2
$8.54M Sell
46,013
-1,590
-3% -$295K 0.1% 66
2025
Q1
$10M Sell
47,603
-568
-1% -$110K 0.13% 56
2024
Q4
$8.56M Buy
48,171
+8,959
+23% +$1.65M 0.11% 62
2024
Q3
$6.73M Buy
39,212
+11,444
+41% +$2.14M 0.09% 66
2024
Q2
$5.06M Buy
27,768
+2,843
+11% +$471K 0.07% 75
2024
Q1
$4.54M Sell
24,925
-455
-2% -$78.4K 0.06% 68
2023
Q4
$3.78M Buy
25,380
+1,607
+7% +$234K 0.06% 69
2023
Q3
$3.2M Buy
23,773
+1,172
+5% +$172K 0.05% 79
2023
Q2
$3.6M Sell
22,601
-6,636
-23% -$973K 0.06% 74
2023
Q1
$4.72M Sell
29,237
-361
-1% -$55.2K 0.08% 75
2022
Q4
$3.97M Buy
29,598
+4,362
+17% +$669K 0.07% 73
2022
Q3
$3.86M Buy
25,236
+1,777
+8% +$255K 0.07% 69
2022
Q2
$3.8M Buy
+23,459
New +$3.58M 0.06% 72

Other funds holding ABBV

Blue Trust's ABBV Position: Q3 2026 in Review

Blue Trust reduced its AbbVie (ABBV) stake by 8.6% in Q3 2026, selling an estimated $930K and leaving 38,455 shares worth $10.1M. The position accounts for 0.11% of the portfolio, ranked #67.

Blue Trust first reported a position in ABBV in Q2 2022 and has held it in 18 quarters since. The position peaked at $10.8M in Q3 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Blue Trust held 38,455 shares of AbbVie worth $10.1M as of Q3 2026.
  • Blue Trust sold 3,627 AbbVie shares in Q3 2026, an estimated $930K.
  • AbbVie made up 0.11% of Blue Trust's portfolio in Q3 2026, its #67 holding.
  • Blue Trust first reported a position in AbbVie in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's AbbVie position peaked at $10.8M in Q3 2025.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.